SABS
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.64
+0.13 (+3.70%)
Rating:B
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.51
Prev. Close
$3.51
Day Low
$3.51
Day High
$3.77
52W Low
$1.85
52W High
$5.15
Market Cap
$0.03B
Volume
0.78M